Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

NMDA receptor (NMDA-R) encephalitis may occur as a post-infectious syndrome following HSV encephalitis. Borrelia burgdorferi is not a well-established infective trigger of NMDA-R antibody encephalitis. There is one previous report of NMDA-R antibodies in association with Lyme disease.We report the case of a 27-year-old woman who presented with acute psychosis. She had a history of tick bite in Slovenia two months previously, followed by headache, flu-like symptoms and diplopia two weeks later. She then developed behavioural disturbance, with disinhibition, disordered thought and paranoia, resistant to antipsychotic medication. MRI brain revealed multiple white matter lesions and diffuse cranial nerve enhancement. CSF was active. Lyme serology (Borrelia IgG and IgM immunoblot) was positive. NMDA-R antibodies were positive (serum and CSF; fixed- and live-cell assays). Infective, autoimmune and neoplastic workup was otherwise unremarkable. She received antimicrobial treatment for neuroborreliosis as well as a course of intravenous immunoglobulin, with gradual resolution of the neuropsychiatric disturbance, normalisation of her neuropsychological assessment and improvement of the MRI appearances. Repeat NMDA-R antibody testing upon convalescence was negative in the serum and CSF (live-cell assay).This is the second reported case of NMDA-R antibody positivity with clinical features of NMDA-R antibody-associated encephalitis in serologically confirmed Lyme disease.

More information Original publication

DOI

10.1136/jnnp-2019-abn-2.25

Type

Conference paper

Publisher

BMJ

Publication Date

2019-12-01T00:00:00+00:00

Volume

90

Pages

e8.3 - e9